RLS Protein Subunit Vaccine (Reliance Life Sciences)

N/A

Report date: 2025/01/26 18:02:02

Base Information

Drug NameRLS Protein Subunit Vaccine (Reliance Life Sciences)
Drug Alias NameRLS Protein Subunit VaccineSARS-CoV-2 Recombinant protein subunit vaccine (Reliance Life Sciences)RelCoVax
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndiaKenya
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReliance Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesReliance Life Sciences
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A